Clinical trials

  • FLUDARABINE PHOSPHATE for High-risk myelodysplastic syndrome | Acute myeloid leukemia
  • ESTRIOL for Vaginal atrophy
  • MEPIVACAINE HYDROCHLORIDE for Ischemic stroke
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Pleural mesothelioma
  • INTERFERON ALFA, INTERLEUKIN-1, INTERLEUKIN-2, RIBONUCLEIC ACID, SPECIFIC NUCLEIC ACID SNA-HLA II, SPECIFIC NUCLEIC ACID SNA-VERU for Non-genital warts | Common warts | Plantar warts | Flat warts
  • Clinical trial in Attention deficit hyperactivity disorder | Borderline personality disorder
  • Autologous adipose-derived mesenchymal stem cells in vitro expanded for Degenerative disc disease
  • NORUCHOLIC ACID for Primary sclerosing cholangitis
  • NAVTEMADLIN for Primary myelofibrosis | Post-polycythemia vera myelofibrosis | Post-essential thrombocythemia myelofibrosis
  • GEMCITABINE for Pancreatic cancer
  • Rosuvastatin; Fenofibrate for Dyslipidaemia
  • 1-4-{[6-AMINO-5-(4-PHENOXY-PHENYL)-PYRIMIDIN-4-YLAMINO]-METHYL}-4-FLUORO-PIPERIDIN-1-YL)-PROPENONE for Myelofibrosis | Indolent systemic mastocytosis | Monoclonal mast cell activation syndrome | Non-monoclonal mast cell activation syndrome